Fractyl Health, Inc. Common Stock (GUTS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 3K | 14K | 43K | 33K | 7K | 36K | 72K |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | -57.14% | -61.11% | -40.28% | 560% | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 24K | 19K | 2K | 109K | 47K |
| COGS % of Revenue | - | - | - | - | - | - | 50% | 55.81% | 57.58% | 28.57% | 302.78% | 65.28% |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 3K | 7K | 19K | 14K | 5K | -73K | 25K |
| Gross Margin % | - | - | - | - | - | 100% | 50% | 44.19% | 42.42% | 71.43% | -202.78% | 34.72% |
| Gross Profit Growth % | - | -100% | -100% | -100% | -100% | -40% | 109.59% | -24% | 600% | - | - | - |
| Operating Expenses | 20.82M | 23.28M | 22.69M | 26.08M | 24.76M | 25.21M | 23.8M | 23M | 21.56M | 12.99M | 13.8M | 11.9M |
| OpEx % of Revenue | - | - | - | - | - | 840433.33% | 170007.14% | 53497.67% | 65321.21% | 185514.29% | 38333.33% | 16527.78% |
| Selling, General & Admin | 5.22M | 6.79M | 5.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.42M | 0 |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | 12272.22% | - |
| Research & Development | 15.6M | 16.49M | 17.46M | 21.15M | 19.43M | 20.28M | 19M | 16.76M | 14.42M | 10.17M | 9.38M | 9.14M |
| R&D % of Revenue | - | - | - | - | - | 676033.33% | 135742.86% | 38981.4% | 43709.09% | 145228.57% | 26061.11% | 12695.83% |
| Other Operating Expenses | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Operating Income | -20.82M | -23.28M | -22.69M | -26.08M | -24.76M | -25.21M | -23.79M | -22.98M | -21.54M | -12.98M | -13.87M | -11.88M |
| Operating Margin % | - | - | - | - | - | -840333.33% | -169957.14% | -53453.49% | -65278.79% | -185442.86% | -38536.11% | -16493.06% |
| Operating Income Growth % | 15.91% | 7.64% | 4.62% | -13.46% | -14.93% | -94.21% | -71.51% | -93.56% | -77.93% | -13.74% | - | - |
| EBITDA | -20.54M | -23M | -22.4M | -25.81M | -24.47M | -24.99M | -23.59M | -22.79M | -21.49M | -12.94M | -13.79M | -11.79M |
| EBITDA Margin % | - | - | - | - | - | -832900% | -168464.29% | -53006.98% | -65118.18% | -184900% | -38302.78% | -16379.17% |
| EBITDA Growth % | 16.06% | 7.93% | 5.01% | -13.23% | -13.87% | -93.05% | -71.04% | -93.28% | -79.16% | -14.22% | - | - |
| D&A (Non-Cash Add-back) | 281K | 279K | 290K | 270K | 290K | 223K | 209K | 192K | 53K | 38K | 84K | 82K |
| EBIT | -20.82M | -23.28M | -22.69M | -26.08M | -24.76M | -25.21M | -23.79M | -22.98M | -21.54M | -12.98M | -13.87M | -11.88M |
| Net Interest Income | 593K | 645K | 166K | 226K | 503K | 726K | 947K | 1.38M | 1.1M | 463K | 226K | 154K |
| Interest Income | 593K | 645K | 166K | 226K | 503K | 726K | 947K | 1.38M | 1.1M | 463K | 226K | 154K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 30.04M | -20.44M | -22.91M | -1.81M | 1.02M | 240K | 621K | 5.76M | 18.22M | -6.2M | -1.87M | -18.36M |
| Pretax Income | 9.22M | -43.73M | -45.6M | -27.89M | -23.73M | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M | -15.75M | -30.23M |
| Pretax Margin % | - | - | - | - | - | -832333.33% | -165521.43% | -40067.44% | -10066.67% | -274000% | -43741.67% | -41988.89% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 9.22M | -43.73M | -45.6M | -27.89M | -23.73M | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M | -15.75M | -30.23M |
| Net Margin % | - | - | - | - | - | -832333.33% | -165521.43% | -40067.44% | -10066.67% | -274000% | -43741.67% | -41988.89% |
| Net Income Growth % | 138.84% | -75.12% | -96.79% | -61.87% | -614.48% | -30.19% | -47.16% | 43.01% | 72.16% | -76.64% | - | - |
| Net Income (Continuing) | 9.22M | -43.73M | -45.6M | -27.89M | -23.73M | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M | -15.75M | -30.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.12 | -0.58 | -0.71 | -0.57 | -0.49 | -0.51 | -0.48 | -0.36 | -0.11 | -0.40 | -0.42 | -0.63 |
| EPS Growth % | 124.49% | -13.73% | -47.92% | -58.33% | -345.45% | -27.5% | -14.29% | 42.86% | 56% | -73.91% | - | - |
| EPS (Basic) | 0.12 | -0.58 | -0.71 | -0.57 | -0.49 | -0.51 | -0.48 | -0.36 | -0.11 | -0.40 | -0.42 | -0.63 |
| Diluted Shares Outstanding | 75.82M | 75.82M | 64.65M | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M |
| Basic Shares Outstanding | 75.82M | 75.82M | 64.65M | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |